Infectious Disease Brands

Molecular diagnostics company specializing in point-of-care PCR testing systems, owned by Danaher Corporation.

Prescription antifungal medication (fluconazole) for treating candidiasis, cryptococcal meningitis, and other fungal infections. Developed by Pfizer, FDA-approved in 1990.

Prescription antiretroviral medication for treating HIV infection by inhibiting integrase enzyme, manufactured and marketed by Merck & Co.

Merck's 23-valent pneumococcal polysaccharide vaccine (PPSV23), FDA approved in 1983 as an expansion of Merck's 14-valent formulation licensed in 1977, providing T-cell independent immune protection against 23 pneumococcal serotypes in adults aged 50 and older and high-risk individuals, now used alongside conjugate vaccines per updated CDC recommendations.

Pfizer's pneumococcal conjugate vaccine franchise, originally developed by Wyeth as Prevnar (PCV7, FDA approved February 17, 2000), succeeded by Prevnar 13 (PCV13, FDA approved February 24, 2010) and Prevnar 20 (PCV20, FDA approved June 8, 2021), one of the world's best-selling vaccines with peak annual revenues exceeding $6 billion.

Oseltamivir antiviral medication invented by Gilead Sciences and licensed to Roche in 1996, FDA approved October 27 1999, that became a cornerstone of global influenza pandemic preparedness stockpiles.

Pfizer's macrolide antibiotic (azithromycin), originally discovered by Pliva in 1980 and licensed to Pfizer, FDA approved in June 1991, widely known as the Z-Pack for its 5-day oral course, with generic azithromycin available since 2005 following patent expiration and a 2013 FDA safety warning regarding QT prolongation risk.